Where can Datopotamab be purchased in China?

Datopotamab (Datopotamab) is a new type of antibody conjugate drug (ADC) targeting TROP2. It is mainly used to treat refractory malignant tumors such as triple-negative breast cancer and non-small cell lung cancer. This drug combines cytotoxic drugs with antibodies to selectively kill tumor cells, reduce damage to normal cells, and improve the therapeutic effect. In recent years, dabrotuzumab has shown good anti-tumor activity and safety in multiple international clinical trials, and has attracted much attention in the field of cancer treatment.

As of 20258 months, dabrotuzumab has not yet been officially approved for marketing in mainland China, so domestic hospitals and pharmacies cannot yet purchase the drug through formal channels. Some domestic scientific research institutions can purchase the drug through agents for scientific research and clinical trials, but it is not allowed to be used for routine treatment. This means that patients currently cannot obtain regular supply of the drug in the country and need to pay attention to its launch progress.

At present, the marketing application for dedabrotuzumab in China has entered the approval stage, and the relevant drug regulatory authorities are reviewing its clinical data and registration information. With the continuous accumulation of clinical trial data and the advancement of the approval process, dedabrotuzumab is expected to officially enter the Chinese market in the near future. By then, this new anti-tumor drug will provide more treatment options for patients with triple-negative breast cancer and non-small cell lung cancer.

Prior to this, patients are not recommended to purchase dabrotomab through informal channels or overseas channels to avoid drug quality and safety risks. It is recommended that patients follow the guidance of professional doctors, pay attention to the latest drug information released by authoritative channels, and wait for its official launch. Choosing formal treatment methods can ensure the safety and efficacy of medication and achieve better treatment results.

Reference materials:https://www.drugs.com/